The authors verified the potential anti-osteoporotic effects of apple-derived nanovesicles using MC3T3-E1 cells, inhibiting osteoporosis by promoting osteoblastogenesis in osteoblastic MC3T3-E1 cells, by regulating the BMP2/Smad1 pathway [126]. The gene discussed is SMAD1; the disease is osteoporosis.